CClinicalTrials.gg
CompletedNCT06149442Updated Aug 18, 2026

The Importance of the Number of Incisions in the Effectiveness of Dry Needling

An interventional study of Dose of five-incisions dry needling technique and Dose of ten-incisions dry needling technique in Neck Pain, sponsored by University of Alcala. Completed at 2 sites in Spain. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-08-18.

Sponsored by University of Alcala · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The dry needling technique is a procedure increasingly used by health professionals.

Dry needling consists of the use of a filiform needle to treat musculoskeletal pain. Currently, the mechanisms by which it is an effective technique are not well understood. One of the aspects not yet evaluated is the best dose in terms of the number of times it is necessary to insert the needle into the patient to achieve the best result.

This research work aims to assess which treatment obtains the best results in the management of patients with chronic neck pain.

Read the detailed description

With the objective of demonstrating how the dose used during the application of the dry needling technique is related to the effectiveness of the treatment, we have designed a study where three different doses of the dry needling technique for the treatment of myofascial trigger points will be compared in the upper trapezius muscle in participants with neck pain.

Randomly, the participants will be distributed to each of the treatment groups and we will measure how the effectiveness of each of the applied doses determines the result of the application of the dry needling technique in the treatment of neck pain.

02

Conditions studied

  • Neck Pain

Browse trials for

Keywords

  • dry needling
  • myofascial trigger point
03

In context

Neck Pain

1,232 studies on the registry are indexed under Neck Pain; 254 are open to participants now.

This study's enrollment of 90 is above the median of 52 across 1,004 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

University of Alcala is the lead sponsor of 123 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Nonspecific mechanical neck pain for more than 3 months.
  • Neck pain of at least VAS 5/10.
  • Reproduction of pain and symptoms subjects on palpation.
  • Pain on passive stretching of the muscle.

Exclusion criteria

Exclusion Criteria:

  • Subjects with previous surgical intervention.
  • Subjects undergoing other intervention (rehabilitation/medication).
  • Positive findings that raise suspicion of cervical radiculopathy:
  • Subjects diagnosed: degenerative arthropathies, inflammatory, systemic conditions (fibromyalgia).
  • Cardiovascular diseases.
  • Whiplash or whiplash.
  • Belenophobia.
  • Dizziness and vertigo.
  • Pregnant.
  • Thyroid disorders.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Dose of five muscle incisions

    Subjects treated in this group will receive an in-out technique with a dosage of five incisions in the myofascial trigger point of the levator scapulae muscle.

    Other: Dose of five-incisions dry needling technique

  • Experimental
    Dose of ten muscle incisions

    Subjects treated in this group will receive an in-out technique with a dosage of ten incisions in the myofascial trigger point of the levator scapulae muscle.

    Other: Dose of ten-incisions dry needling technique

  • Experimental
    Dose of fifteen muscle incisions

    Subjects treated in this group will receive an in-out technique with a dosage of fifteen incisions in the myofascial trigger point of the levator scapulae muscle.

    Other: Dose of fifteen-incisions dry needling technique

Interventions

  • OtherDose of five-incisions dry needling technique

    Once we have assessed the existence of a myofascial trigger point in the levator scapulae muscle, and while the subject is in lateral decubitus on the same side, with a forceps palpation, we apply a rapid in /out dry needling technique (five incisions).

  • OtherDose of ten-incisions dry needling technique

    Once we have assessed the existence of a myofascial trigger point in the levator scapulae muscle, and while the subject is in lateral decubitus on the same side, with a forceps palpation, we apply a rapid in /out dry needling technique (ten incisions).

  • OtherDose of fifteen-incisions dry needling technique

    Once we have assessed the existence of a myofascial trigger point in the levator scapulae muscle, and while the subject is in lateral decubitus on the same side, with a forceps palpation, we apply a rapid in /out dry needling technique (fifteen incisions).

06

What researchers measure

Primary outcomes

  1. Neck pain

    Visual Analog Scale (VAS). VAS is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions. It is a straight horizontal line of fixed length, usually 100 mm where 0 is no pain and 10 is the worst possible pain.

    Time frame: Change From Baseline in Pain Scores on the Visual Analog Scale at three month.

Secondary outcomes

  1. Disability (Neck disability index)

    This questionnaire has been designed to give us information as to how your neck pain has affected your ability to manage in everyday life. It´s value ranges from 0 to 10 to 50 points, where 0 is the absence of disability and 50 is the highest degree of disability.

    Time frame: Change From Baseline in Pain Scores on the Visual Analog Scale at three month.

  2. Pain catastrophizing

    Pain Catastrophizing Scale (PCS). The PCS is a 13-item instrumen that task participants to reflect on past painful experiences, and to indicate the degree to which they experienced each of 13 thoughts or feelings when experiencing pain, on 5-point scales with the end points (0) not at all and (4) all the time. The PCS total scores range from 0 - 52. 0 is the best result and 52 is the worst result.

    Time frame: Change From Baseline in Pain Scores on the Visual Analog Scale at three month.

  3. kinesiophobia

    The Tampa Scale of Kinesiophobia (TSK) describe patient circumstances characterised by an "excessive, irrational, and debilitating fear of physical movement and activity resulting from a feeling of vulnerability to painful injury or reinjury. The TSK is a 17 item assessment checklist.The 17 item TSK total scores range from 17 to 68 where the lowest 17 means no or negligible kinesiophobia, and the higher scores indicate an increasing degree of kinesiophobia.

    Time frame: Change From Baseline in Pain Scores on the Visual Analog Scale at three month.

  4. The Global Rating of Change (GRoC)

    It's a scale that assesses whether the patient condition has gotten worse, better, or stayed

    Time frame: Change From Baseline in Pain Scores on the Visual Analog Scale at three month.

07

Study locations

2 sites
  • Centro Investigación Fisioterapia y Dolor
    Alcalá de Henares, Madrid 28805, Spain
  • Physiotherapy and Pain Institute
    Alcalá de Henares, Madrid 28805, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06149442
Lead sponsor
University of Alcala
Responsible party
Prof. Dr. Daniel Pecos Martín (Principal investigator, University of Alcala) — Principal investigator
First posted
Nov 29, 2023
Start date
Dec 4, 2023
Primary completion
Jan 20, 2026
Completion
Jun 20, 2026
Last update
Aug 18, 2026

Study contacts

Daniel Pecos-Martin, PhD
study director · Alcalá University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion